PCV21 EFFECTS OF AZILSARTAN MEDOXOMIL VERSUS VALSARTAN AND OLMESARTAN MEDOXOMIL ON THE ACHIEVEMENT OF SYSTOLIC BLOOD PRESSURE GOALS AMONG HYPERTENSIVE PATIENTS WITH DIABETES
Abstract
Authors
M. Sussman M. Leahy M. Friedman J. Menzin C. Nichols P. Neumann S.D. Sullivan